Review
Open access
Oct 2026
CAR-NK cell-derived exosomes in cancer therapy: bridging cellular immunotherapy and nanomedicine
Chimeric antigen receptor-engineered natural killer (CAR-NK) cell therapy has emerged as a promising cancer treatment by combining the antigen specificity of CAR engineering with the intrinsic cytotoxicity of NK cells. Compared with CAR-T cell therapy, CAR-NK cells exhibit a lower risk of graft-versus-host disease (GVH...
M. Ganjalikhani-Hakemi, Zohreh Saltanatpori, Ling-Qi Zhou et al.
· Frontiers in Immunology · 0 citations